GW29-e0785 Statin in combination with β-blocker therapy reduces the risk of major adverse cardiovascular events in patients with acute coronary syndrome

Early initiation of statins or beta blockers alone have been advocated to improved event-free survival in patients with acute coronary syndrome(ACS), but the benefits of the combined treatment remains to be evaluated. Thus, we assessed the impact of statin in combination with β-blocker therapy on